Closed-loop insulin delivery: from bench to clinical practice (Q37846089)

24 August 2017

1 reference

title

Closed-loop insulin delivery: from bench to clinical practice (English)

1 reference

24 August 2017

1 reference

Roman Hovorka

1

0 references

language of work or name

1 reference

22 February 2011

1 reference

full work available at URL

24 August 2017

http://www.nature.com/articles/nrendo.2011.32.pdf

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

http://www.nature.com/articles/nrendo.2011.32

25 November 2024

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Nature Reviews Endocrinology

25 November 2024

published in

1 reference

24 August 2017

volume

7

1 reference

24 August 2017

issue

7

1 reference

24 August 2017

page(s)

385-395

1 reference

Closed-loop insulin delivery-the path to physiological glucose control

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

What is artificial endocrine pancreas? Mechanism and history

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Artificial pancreas: an emerging approach to treat Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

The future of continuous glucose monitoring: closed loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Continuous glucose monitoring and closed-loop systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Closed-loop insulin delivery - what lies between where we are and where we are going?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Management of hyperglycemia in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Tight glycemic control and computerized decision-support systems: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Clinical review: Realistic expectations and practical use of continuous glucose monitoring for the endocrinologist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Minimally-invasive and non-invasive continuous glucose monitoring systems: indications, advantages, limitations and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Continuous glucose monitoring: roadmap for 21st century diabetes therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Continuous glucose monitoring and intensive treatment of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

The effect of continuous glucose monitoring in well-controlled type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Model predictive control of type 1 diabetes: an in silico trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

A model-based algorithm for blood glucose control in type I diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

An Artificial Endocrine Pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

An improved PID switching control strategy for type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

MD-logic artificial pancreas system: a pilot study in adults with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Adaptive closed-loop control provides blood-glucose regulation using dual subcutaneous insulin and glucagon infusion in diabetic Swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

A simulation study of an inverse controller for closed- and semiclosed-loop control in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

A closed-loop artificial pancreas using model predictive control and a sliding meal size estimator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Closed-loop control and advisory mode evaluation of an artificial pancreatic Beta cell: use of proportional-integral-derivative equivalent model-based controllers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Model-based blood glucose control for Type 1 diabetes via parametric programming

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Neural predictive controller for insulin delivery using the subcutaneous route

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Telemedical artificial pancreas: PARIS (Pancreas Artificial Telemedico Inteligente) research project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Enhanced 911/global position system wizard: a telemedicine application for the prevention of severe hypoglycemia--monitor, alert, and locate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Control to range for diabetes: functionality and modular architecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Safety constraints in an artificial pancreatic beta cell: an implementation of model predictive control with insulin on board

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Suspended insulin infusion during overnight closed-loop glucose control in children and adolescents with Type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Closed-loop control of artificial pancreatic Beta -cell in type 1 diabetes mellitus using model predictive iterative learning control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Diabetes: Models, Signals, and Control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Comparison of the numerical and clinical accuracy of four continuous glucose monitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Comparison of accuracy and safety of the SEVEN and the Navigator continuous glucose monitoring systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Analysis of time lags and other sources of error of the DexCom SEVEN continuous glucose monitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Accuracy of the 5-day FreeStyle Navigator Continuous Glucose Monitoring System: comparison with frequent laboratory reference measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Time lag characterization of two continuous glucose monitoring systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Measurement delay associated with the Guardian RT continuous glucose monitoring system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Delays in minimally invasive continuous glucose monitoring devices: a review of current technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Detection of hypoglycemia with continuous interstitial and traditional blood glucose monitoring using the FreeStyle Navigator Continuous Glucose Monitoring System.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Variability of insulin absorption and insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

The dawn phenomenon revisited: implications for diabetes therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Daily stress and glycaemic control in Type 1 diabetes: individual differences in magnitude, direction, and timing of stress-reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

The effect of evening alcohol consumption on next-morning glucose control in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Age-dependent basal insulin patterns in children with type 1 diabetes treated with continuous subcutaneous insulin infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Analysis of guidelines for basal-bolus insulin dosing: basal insulin, correction factor, and carbohydrate-to-insulin ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Feasibility of automating insulin delivery for the treatment of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Detection of a meal using continuous glucose monitoring: implications for an artificial beta-cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Glucose requirements to maintain euglycemia after moderate-intensity afternoon exercise in adolescents with type 1 diabetes are increased in a biphasic manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Physical activity-the major unaccounted impediment to closed loop control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Closed-loop insulin delivery using a subcutaneous glucose sensor and intraperitoneal insulin delivery: feasibility study testing a new model for the artificial pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

A method for assessing quality of control from glucose profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Hypoglycemia: still the limiting factor in the glycemic management of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Modular artificial beta-cell system: a prototype for clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Duration of nocturnal hypoglycemia before seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Is an automatic pump suspension feature safe for children with type 1 diabetes? An exploratory analysis with a closed-loop system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Hypoglycemia: incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Parental attitudes towards overnight closed-loop glucose control in children with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Evaluation of the effect of gain on the meal response of an automated closed-loop insulin delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

A feasibility study of bihormonal closed-loop blood glucose control using dual subcutaneous infusion of insulin and glucagon in ambulatory diabetic swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

In silico preclinical trials: methodology and engineering guide to closed-loop control in type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Evaluation of glucose controllers in virtual environment: methodology and sample application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Simulation environment to evaluate closed-loop insulin delivery systems in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Closing the loop: the adicol experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Effects of pulsatile subcutaneous injections of insulin lispro on plasma insulin concentration levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Physical activity into the meal glucose-insulin model of type 1 diabetes: in silico studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

A simulation model of glucose regulation in the critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Identification of intraday metabolic profiles during closed-loop glucose control in individuals with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

The use of an Energy Monitor in the management of diabetes: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

FDA's proactive role in the development of an artificial pancreas for the treatment of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Accelerated pharmacokinetics and glucodynamics of prandial insulins injected with recombinant human hyaluronidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

A novel insulin formulation with a more rapid onset of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Pramlintide Reduces Postprandial Glucose Excursions When Added to Regular Insulin or Insulin Lispro in Subjects With Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Use of the site of subcutaneous insulin administration for the measurement of glucose in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Psychosocial factors associated with use of continuous glucose monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Perceptions of psychosocial factors and the insulin pump

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

A bihormonal closed-loop artificial pancreas for type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

A 10-s sprint performed prior to moderate-intensity exercise prevents early post-exercise fall in glycaemia in individuals with type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Continuous in vivo determination of blood glucose in human subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

The Artificial Beta Cell - A Continuous Control of Blood Sugar by External Regulation of Insulin Infusion (Glucose Controlled Insulin Infusion System)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Automated overnight closed-loop glucose control in young children with type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Insulin requirement of simple and complex carbohydrate foods in type 1 (insulin-dependent) CSII-treated diabetic subjects, obtained by biostator. Correlation with glycaemic index

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

The need for a glycemia modeling comparison workshop to facilitate development of an artificial pancreas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Can we really close the loop and how soon? Accelerating the availability of an artificial pancreas: a roadmap to better diabetes outcomes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group

31 March 2020

1 reference

12 December 2020

Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT.

1 reference

12 December 2020

Dead-in-bed syndrome in young diabetic patients

1 reference

12 December 2020

Feedback control dynamics for glucose controlled insulin infusion system

1 reference

12 December 2020

Hyperinsulinemia prevents prolonged hyperglycemia after intense exercise in insulin-dependent diabetic subjects

1 reference

12 December 2020

Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies

1 reference

12 December 2020

The development of Biostator, a Glucose Controlled Insulin Infusion System (GCIIS)

1 reference

12 December 2020

The Journal of Clinical Endocrinology and Metabolism

68

79

1049

RJ Sigal

1994

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

American Journal of Physiology

25 November 2024

102

282

E992

R Hovorka

2002

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2011.32

25 November 2024

Identifiers

1 reference

release_d4bobqwl2bayfmcplx6bsbxakm

24 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d4bobqwl2bayfmcplx6bsbxakm

24 November 2022

mapped directly with Wikidata item

1 reference